Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.

Abstract excerpt

Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31-December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19
• Share to COVID-19 Drug Treatment
• Share to Drug Resistance, Viral